EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigation of Thrombolysis with Reteplase on Vital Signs, Right Ventricular Parameters and Clinical Symptoms of Patients with Acute Massive and Sub-massive Pulmonary Embolism

Fatemeh Jafari, Nazanin Hanafi Bojd, Fateme Mahdizadeh

Journal of Reports in Pharmaceutical Sciences · 2024

DOI: 10.5812/jrps-146804 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Reports in Pharmaceutical Sciences, 2024. Verfasst von Fatemeh Jafari und 2 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to evaluate the effectiveness of thrombolysis with reteplase in patients with acute pulmonary embolism (PE) requiring thrombolytic treatment in the cardiac wards of Valiasr and Razi hospitals in Birjand, Iran. The study was conducted over a five-year period.

Methods

The study included patients with acute massive and sub-massive PE who received thrombolysis with reteplase from early 2016 to late 2020. Additionally, a one-year follow-up was conducted to monitor any complications.

Results

A total of 28 patients participated in this study, with an average age of 54 ± 12 years. Findings showed that hypotension, chest pain, and hemoptysis resolved within 48 hours after reteplase administration. Reteplase also had a significant impact on improving hypoxemia (SPO2) and stabilizing vital signs, including heart rate (HR), respiratory rate (RR), and blood pressure (BP), as well as enhancing right ventricular (RV) function and reducing pulmonary artery pressure. The majority of patients (55%) had no deep vein involvement, and most did not report complications after discharge.

Conclusions

This study observed that reteplase was highly effective, leading to rapid clinical improvement without an increased risk of significant bleeding or mortality. Although limited by its retrospective nature, the study suggests that reteplase is a viable treatment option for PE.

Zitieren

APA

Jafari, F., Bojd, N. H., & Mahdizadeh, F. (2024). Investigation of Thrombolysis with Reteplase on Vital Signs, Right Ventricular Parameters and Clinical Symptoms of Patients with Acute Massive and Sub-massive Pulmonary Embolism. Journal of Reports in Pharmaceutical Sciences. https://doi.org/10.5812/jrps-146804

Vancouver

Jafari F, Bojd NH, Mahdizadeh F. Investigation of Thrombolysis with Reteplase on Vital Signs, Right Ventricular Parameters and Clinical Symptoms of Patients with Acute Massive and Sub-massive Pulmonary Embolism. Journal of Reports in Pharmaceutical Sciences. 2024. doi:10.5812/jrps-146804

BibTeX
@article{Jafari2024,
  author = {Jafari, Fatemeh and Bojd, Nazanin Hanafi and Mahdizadeh, Fateme},
  title = {Investigation of Thrombolysis with Reteplase on Vital Signs, Right Ventricular Parameters and Clinical Symptoms of Patients with Acute Massive and Sub-massive Pulmonary Embolism},
  journal = {Journal of Reports in Pharmaceutical Sciences},
  year = {2024},
  doi = {10.5812/jrps-146804}
}
Kostenlos starten →